You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 2, 2024

~ Buy the SODIUM PHENYLACETATE AND SODIUM BENZOATE (sodium benzoate; sodium phenylacetate) Drug Profile, 2024 PDF Report in the Report Store ~

SODIUM PHENYLACETATE AND SODIUM BENZOATE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Sodium Phenylacetate And Sodium Benzoate patents expire, and when can generic versions of Sodium Phenylacetate And Sodium Benzoate launch?

Sodium Phenylacetate And Sodium Benzoate is a drug marketed by Ailex Pharms Llc, Maia Pharms Inc, and Navinta Llc. and is included in five NDAs.

The generic ingredient in SODIUM PHENYLACETATE AND SODIUM BENZOATE is sodium benzoate; sodium phenylacetate. There are one thousand four hundred and seventy-two drug master file entries for this compound. Eight suppliers are listed for this compound. Additional details are available on the sodium benzoate; sodium phenylacetate profile page.

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for SODIUM PHENYLACETATE AND SODIUM BENZOATE?
  • What are the global sales for SODIUM PHENYLACETATE AND SODIUM BENZOATE?
  • What is Average Wholesale Price for SODIUM PHENYLACETATE AND SODIUM BENZOATE?
Summary for SODIUM PHENYLACETATE AND SODIUM BENZOATE
US Patents:0
Applicants:3
NDAs:5
Finished Product Suppliers / Packagers: 6
Raw Ingredient (Bulk) Api Vendors: 2
Clinical Trials: 4
Patent Applications: 1
What excipients (inactive ingredients) are in SODIUM PHENYLACETATE AND SODIUM BENZOATE?SODIUM PHENYLACETATE AND SODIUM BENZOATE excipients list
DailyMed Link:SODIUM PHENYLACETATE AND SODIUM BENZOATE at DailyMed
Drug patent expirations by year for SODIUM PHENYLACETATE AND SODIUM BENZOATE
Recent Clinical Trials for SODIUM PHENYLACETATE AND SODIUM BENZOATE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
TakedaPhase 1
Horizon Pharma Ireland, Ltd., Dublin IrelandPhase 2
Horizon Pharma Ireland, Ltd., Dublin IrelandPhase 1

See all SODIUM PHENYLACETATE AND SODIUM BENZOATE clinical trials

Pharmacology for SODIUM PHENYLACETATE AND SODIUM BENZOATE

US Patents and Regulatory Information for SODIUM PHENYLACETATE AND SODIUM BENZOATE

SODIUM PHENYLACETATE AND SODIUM BENZOATE is protected by zero US patents and one FDA Regulatory Exclusivity.

FDA Regulatory Exclusivity protecting SODIUM PHENYLACETATE AND SODIUM BENZOATE

COMPETITIVE GENERIC THERAPY
Exclusivity Expiration: ⤷  Sign Up

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Ailex Pharms Llc SODIUM PHENYLACETATE AND SODIUM BENZOATE sodium benzoate; sodium phenylacetate SOLUTION;INTRAVENOUS 207096-001 Feb 24, 2016 AP RX No Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Navinta Llc SODIUM PHENYLACETATE AND SODIUM BENZOATE sodium benzoate; sodium phenylacetate SOLUTION;INTRAVENOUS 205880-001 Aug 4, 2016 AP RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Maia Pharms Inc SODIUM PHENYLACETATE AND SODIUM BENZOATE sodium benzoate; sodium phenylacetate SOLUTION;INTRAVENOUS 208521-001 May 8, 2017 AP RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Maia Pharms Inc SODIUM PHENYLACETATE AND SODIUM BENZOATE sodium benzoate; sodium phenylacetate SOLUTION;INTRAVENOUS 215025-001 Jun 10, 2021 AP RX Yes Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Navinta Llc SODIUM PHENYLACETATE AND SODIUM BENZOATE sodium benzoate; sodium phenylacetate SOLUTION;INTRAVENOUS 217526-001 Jul 14, 2023 AP RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.